New Genetic Biomarkers Could Predict Pancreatic Neuroendocrine Tumor Risk
Research identifies genetic and environmental factors that may help predict who develops pancreatic neuroendocrine tumors and their outcomes.
4859 articles
Research identifies genetic and environmental factors that may help predict who develops pancreatic neuroendocrine tumors and their outcomes.
Comprehensive review examines peptides like BPC-157 and TB-500 for wound healing, muscle repair, and recovery optimization in orthopedic medicine.
Comprehensive analysis reveals why platelet-rich plasma outcomes vary and provides framework for standardization.
Comprehensive review reveals how PRP's growth factors, immune cells, and exosomes work together to enhance tissue repair across multiple medical specialties.
New review reveals how immune cells orchestrate tissue scarring across organs, offering therapeutic targets for fibrosis affecting nearly a billion people.
New research reveals how specific gut microbes create metabolites that directly communicate with the brain to prevent neurodegeneration.
Multiomics study reveals gut microbiome shifts and inflammation markers detectable in earliest stages of cognitive decline.
Study reveals how depleted beneficial gut bacteria leads to brain atrophy and cognitive decline in metabolic syndrome patients.
Massive genetic study reveals specific gut microbes alter brain anatomy and cause mental health conditions through structural brain changes.
New research reveals how intestinal cells make steroid hormones that communicate with gut bacteria and influence brain health.
New cerebrospinal fluid protein biomarker can predict which Alzheimer's patients will maintain cognitive function despite brain pathology.
Advanced cardiac MRI strain measurements identify diabetic patients at highest risk for heart failure hospitalization and death.